Literature DB >> 2050371

Is DNA ploidy and proliferative activity of prognostic value in advanced gastric carcinoma?

M I Filipe1, J Rosa, A Sandey, P R Imrie, M G Ormerod, R W Morris.   

Abstract

We analyzed the DNA content of 116 gastric carcinomas and lymph node metastasis in 53 of these using flow cytometry on archival material. DNA index and proliferative activity (% S-phase) values were obtained in 111 and 76 tumors, respectively, and survival rates were obtained for 108. Tumor classification was based on histologic type, grade, and growth pattern and stage. All were advanced gastric carcinomas. Fifty four tumors (47%) were aneuploid. In single variable analysis, survival was related to stage (muscularis propria versus serosa P = .002) and lymph node metastasis (P = .04). Infiltrative tumor growth had a slightly worse prognosis (P = .06). In multifactorial analysis, tumor stage was the only independent prognostic factor. Neither DNA ploidy nor % S-phase values had any effect on survival, although, patients with tumors with higher DNA indexes (greater than 1.7) showed a tendency toward worse survival rates. We failed to prove the prognostic value of DNA ploidy in gastric carcinoma. Before its effect is ruled out, some factors have to be considered: (1) all tumors were in advanced stage and the true effect of ploidy on survival may have been diluted, (2) quality of fixation--near diploid aneuploid populations may have been overlooked, and (3) intratumoral DNA ploidy heterogeneity can cause sample discrepancy (20% in our series).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050371     DOI: 10.1016/0046-8177(91)90085-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.

Authors:  S Jain; M I Filipe; P A Hall; N Waseem; D P Lane; D A Levison
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

Review 2.  Pathologic prognostic factors for gastrointestinal cancer.

Authors:  T Ismail; M T Hallissey; J W Fielding
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

3.  DNA ploidy and biologic aggressiveness of gastric adenocarcinoma in Chinese.

Authors:  K L Shen; C H Chu
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

4.  DNA ploidy in early gastric carcinoma (T1): a flow cytometric study of 100 European cases.

Authors:  M J Brito; M I Filipe; G T Williams; H Thompson; M G Ormerod; J Titley
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

5.  Measurement of cell proliferation in gastric carcinoma: comparative analysis of Ki-67 and proliferative cell nuclear antigen (PCNA).

Authors:  J C Rosa; R Mendes; M I Filipe; R W Morris
Journal:  Histochem J       Date:  1992-02

6.  Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.

Authors:  K H Lee; J S Lee; J H Lee; S W Kim; C Suh; W K Kim; S H Kim; Y I Min; B S Kim; K C Park; M S Lee; H S Sun
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

7.  DNA analysis by flow cytometry in early gastric cancer.

Authors:  J M Kim; D K Lee; Y K Kim; S K Baik; C I Lee; S O Kwon; S H Jung
Journal:  Korean J Intern Med       Date:  1997-06       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.